Cholecystokinin-octapeptide fragments: Binding to brain cholecystokinin receptors

Martha Knight, Carol A. Tamminga, Luca Steardo, Mary E. Beck, Paolo Barone, Thomas N. Chase

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Structural determinants of cholecystokinin octapeptide (CCK-8) binding to central nervous system receptors have been studied to assess the relative importance of the amino and the carboxyl end of the active peptide sequence, CCK-(26-33). The relative ability to inhibit equilibrium binding of [125I]CCK-33 to guinea pig cortical membranes was determined for a series of amino and carboxyl terminal fragments of CCK-8. While N-acetyl CCK-(26-29), N-acetyl CCK-(26-30) amide and N-acetyl CCK-(26-31) amide were inactive, the N-acetyl CCK-(26-32) amide fragment displayed binding to central receptors. Of the carboxyl terminal peptide fragments, both CCK-(29-33) and CCK-(30-33) bound less potently than CCK-8; CCK-(31-33) interacted more weakly than the tetra- and pentapeptide, but with a higher affinity to brain receptors than to peripheral receptors. The heptapeptide, CCK-(26-32) amide, and the tripeptide, CCK-(31-33), are known to antagonize CCK action at peripheral receptors. The heptapeptide bound to central receptors 25 times more potently than a known peripheral antagonist, dibutyryl cyclic GMP. Thus these peptides may act centrally to oppose CCK-8 mediated functions.

Original languageEnglish (US)
Pages (from-to)49-55
Number of pages7
JournalEuropean Journal of Pharmacology
Volume105
Issue number1-2
DOIs
StatePublished - Oct 1 1984

Fingerprint

Cholecystokinin Receptors
Sincalide
Cholecystokinin
Amides
Brain
Dibutyryl Cyclic GMP
Tetragastrin
Peptides
Peptide Fragments
Guinea Pigs
Central Nervous System
Membranes

Keywords

  • Brain receptors
  • CCK-5, CCK-4, CCK-3
  • Cholecystokinin antagonists
  • Cholecystokinin fragments
  • Cholecystokinin receptors
  • Guinea pig cortical membrane
  • N-terminal CCK fragment peptides

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Cholecystokinin-octapeptide fragments : Binding to brain cholecystokinin receptors. / Knight, Martha; Tamminga, Carol A.; Steardo, Luca; Beck, Mary E.; Barone, Paolo; Chase, Thomas N.

In: European Journal of Pharmacology, Vol. 105, No. 1-2, 01.10.1984, p. 49-55.

Research output: Contribution to journalArticle

Knight, Martha ; Tamminga, Carol A. ; Steardo, Luca ; Beck, Mary E. ; Barone, Paolo ; Chase, Thomas N. / Cholecystokinin-octapeptide fragments : Binding to brain cholecystokinin receptors. In: European Journal of Pharmacology. 1984 ; Vol. 105, No. 1-2. pp. 49-55.
@article{18891870bb4540b88a3337bee53466bf,
title = "Cholecystokinin-octapeptide fragments: Binding to brain cholecystokinin receptors",
abstract = "Structural determinants of cholecystokinin octapeptide (CCK-8) binding to central nervous system receptors have been studied to assess the relative importance of the amino and the carboxyl end of the active peptide sequence, CCK-(26-33). The relative ability to inhibit equilibrium binding of [125I]CCK-33 to guinea pig cortical membranes was determined for a series of amino and carboxyl terminal fragments of CCK-8. While N-acetyl CCK-(26-29), N-acetyl CCK-(26-30) amide and N-acetyl CCK-(26-31) amide were inactive, the N-acetyl CCK-(26-32) amide fragment displayed binding to central receptors. Of the carboxyl terminal peptide fragments, both CCK-(29-33) and CCK-(30-33) bound less potently than CCK-8; CCK-(31-33) interacted more weakly than the tetra- and pentapeptide, but with a higher affinity to brain receptors than to peripheral receptors. The heptapeptide, CCK-(26-32) amide, and the tripeptide, CCK-(31-33), are known to antagonize CCK action at peripheral receptors. The heptapeptide bound to central receptors 25 times more potently than a known peripheral antagonist, dibutyryl cyclic GMP. Thus these peptides may act centrally to oppose CCK-8 mediated functions.",
keywords = "Brain receptors, CCK-5, CCK-4, CCK-3, Cholecystokinin antagonists, Cholecystokinin fragments, Cholecystokinin receptors, Guinea pig cortical membrane, N-terminal CCK fragment peptides",
author = "Martha Knight and Tamminga, {Carol A.} and Luca Steardo and Beck, {Mary E.} and Paolo Barone and Chase, {Thomas N.}",
year = "1984",
month = "10",
day = "1",
doi = "10.1016/0014-2999(84)90647-2",
language = "English (US)",
volume = "105",
pages = "49--55",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Cholecystokinin-octapeptide fragments

T2 - Binding to brain cholecystokinin receptors

AU - Knight, Martha

AU - Tamminga, Carol A.

AU - Steardo, Luca

AU - Beck, Mary E.

AU - Barone, Paolo

AU - Chase, Thomas N.

PY - 1984/10/1

Y1 - 1984/10/1

N2 - Structural determinants of cholecystokinin octapeptide (CCK-8) binding to central nervous system receptors have been studied to assess the relative importance of the amino and the carboxyl end of the active peptide sequence, CCK-(26-33). The relative ability to inhibit equilibrium binding of [125I]CCK-33 to guinea pig cortical membranes was determined for a series of amino and carboxyl terminal fragments of CCK-8. While N-acetyl CCK-(26-29), N-acetyl CCK-(26-30) amide and N-acetyl CCK-(26-31) amide were inactive, the N-acetyl CCK-(26-32) amide fragment displayed binding to central receptors. Of the carboxyl terminal peptide fragments, both CCK-(29-33) and CCK-(30-33) bound less potently than CCK-8; CCK-(31-33) interacted more weakly than the tetra- and pentapeptide, but with a higher affinity to brain receptors than to peripheral receptors. The heptapeptide, CCK-(26-32) amide, and the tripeptide, CCK-(31-33), are known to antagonize CCK action at peripheral receptors. The heptapeptide bound to central receptors 25 times more potently than a known peripheral antagonist, dibutyryl cyclic GMP. Thus these peptides may act centrally to oppose CCK-8 mediated functions.

AB - Structural determinants of cholecystokinin octapeptide (CCK-8) binding to central nervous system receptors have been studied to assess the relative importance of the amino and the carboxyl end of the active peptide sequence, CCK-(26-33). The relative ability to inhibit equilibrium binding of [125I]CCK-33 to guinea pig cortical membranes was determined for a series of amino and carboxyl terminal fragments of CCK-8. While N-acetyl CCK-(26-29), N-acetyl CCK-(26-30) amide and N-acetyl CCK-(26-31) amide were inactive, the N-acetyl CCK-(26-32) amide fragment displayed binding to central receptors. Of the carboxyl terminal peptide fragments, both CCK-(29-33) and CCK-(30-33) bound less potently than CCK-8; CCK-(31-33) interacted more weakly than the tetra- and pentapeptide, but with a higher affinity to brain receptors than to peripheral receptors. The heptapeptide, CCK-(26-32) amide, and the tripeptide, CCK-(31-33), are known to antagonize CCK action at peripheral receptors. The heptapeptide bound to central receptors 25 times more potently than a known peripheral antagonist, dibutyryl cyclic GMP. Thus these peptides may act centrally to oppose CCK-8 mediated functions.

KW - Brain receptors

KW - CCK-5, CCK-4, CCK-3

KW - Cholecystokinin antagonists

KW - Cholecystokinin fragments

KW - Cholecystokinin receptors

KW - Guinea pig cortical membrane

KW - N-terminal CCK fragment peptides

UR - http://www.scopus.com/inward/record.url?scp=0021211934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021211934&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(84)90647-2

DO - 10.1016/0014-2999(84)90647-2

M3 - Article

C2 - 6092115

AN - SCOPUS:0021211934

VL - 105

SP - 49

EP - 55

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-2

ER -